Overview
Despite the existence of comprehensive severe asthma guidelines and a severe asthma registry, Japan’s score in Policy Context is well below the average due to the lack of a national asthma strategy and limited alignment of national care guidelines with international guidelines. Importantly, Japan ranks last in terms of Access and Care Coverage. This can be attributed to limited access to treatment and medicines (including biologics), diagnostics, and digital therapeutics. In spite of this, Japan has the highest score in Disease Burden, with relatively low scores across most indicators except the percentage of deaths attributable to asthma, where Japan ranks slightly below average and is driven primarily by the lowest rate of adult obesity among the selected countries.
How does Japan perform in each category?
Provides further insights into how Japan scores across each Index category
Japan takeaways
Data from the Severe Asthma Index revealed the following key insights about severe asthma care in Japan
Japan has strong severe asthma guidelines and the existence of severe asthma registries
Japan has the lowest Access and Care Coverage score, primarily due to limited access to treatments, diagnostics and digital therapeutics
Japan has the highest Disease Burden score and lowest rate of adult obesity
Compare Japan to other countries
Select different countries to see how they scored across each of the 5 categories and overall